169 related articles for article (PubMed ID: 30953693)
21. Lactoferrin and lactoferricin B reduce adhesion and biofilm formation in the intestinal symbionts Bacteroides fragilis and Bacteroides thetaiotaomicron.
de Sá Almeida JS; de Oliveira Marre AT; Teixeira FL; Boente RF; Domingues RMCP; de Paula GR; Lobo LA
Anaerobe; 2020 Aug; 64():102232. PubMed ID: 32634470
[TBL] [Abstract][Full Text] [Related]
22. Molecular Mechanism of the Protective Effect of Zerumbone on Lipopolysaccharide-Induced Inflammation of THP-1 Cell-Derived Macrophages.
Kim MJ; Yun JM
J Med Food; 2019 Jan; 22(1):62-73. PubMed ID: 30383973
[TBL] [Abstract][Full Text] [Related]
23. The role of efflux pumps in Bacteroides fragilis resistance to antibiotics.
Ghotaslou R; Yekani M; Memar MY
Microbiol Res; 2018 May; 210():1-5. PubMed ID: 29625653
[TBL] [Abstract][Full Text] [Related]
24. Metabolic profiling of Zingiber zerumbet following Pythium myriotylum infection: investigations on the defensive role of the principal secondary metabolite, zerumbone.
Keerthi D; Geethu C; Nair RA; Pillai P
Appl Biochem Biotechnol; 2014 Mar; 172(5):2593-603. PubMed ID: 24414941
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial susceptibility testing of Bacteroides fragilis using the MALDI Biotyper antibiotic susceptibility test rapid assay (MBT-ASTRA).
Justesen US; Acar Z; Sydenham TV; Johansson Å;
Anaerobe; 2018 Dec; 54():236-239. PubMed ID: 29501419
[TBL] [Abstract][Full Text] [Related]
26. In vitro vasoactivity of zerumbone from Zingiber zerumbet.
Fusi F; Durante M; Sgaragli G; Khanh PN; Son NT; Huong TT; Huong VN; Cuong NM
Planta Med; 2015 Mar; 81(4):298-304. PubMed ID: 25714723
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of overexpression of multiple RND-family efflux pumps in Bacteroides fragilis isolates.
Pumbwe L; Chang A; Smith RL; Wexler HM
J Antimicrob Chemother; 2006 Sep; 58(3):543-8. PubMed ID: 16840432
[TBL] [Abstract][Full Text] [Related]
28. Exploring the immunomodulatory and anticancer properties of zerumbone.
Haque MA; Jantan I; Arshad L; Bukhari SNA
Food Funct; 2017 Oct; 8(10):3410-3431. PubMed ID: 28714500
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of MarR gene homologs increases susceptibility to antimicrobials in Bacteroides fragilis.
Silva CMG; Silva DNDS; Costa SBD; Almeida JSS; Boente RF; Teixeira FL; Domingues RMCP; Lobo LA
Braz J Microbiol; 2018; 49(1):200-206. PubMed ID: 28847541
[TBL] [Abstract][Full Text] [Related]
30. Bacteroides fragilis BmeABC efflux systems additively confer intrinsic antimicrobial resistance.
Pumbwe L; Ueda O; Yoshimura F; Chang A; Smith RL; Wexler HM
J Antimicrob Chemother; 2006 Jul; 58(1):37-46. PubMed ID: 16757501
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe.
Hedberg M; Nord CE;
Clin Microbiol Infect; 2003 Jun; 9(6):475-88. PubMed ID: 12848722
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of Bacteroides fragilis resistance to metronidazole.
Ghotaslou R; Bannazadeh Baghi H; Alizadeh N; Yekani M; Arbabi S; Memar MY
Infect Genet Evol; 2018 Oct; 64():156-163. PubMed ID: 29936037
[TBL] [Abstract][Full Text] [Related]
33. Zerumbone Inhibits
Woo HJ; Yang JY; Lee P; Kim JB; Kim SH
Molecules; 2021 May; 26(9):. PubMed ID: 34062878
[No Abstract] [Full Text] [Related]
34. Study the antibacterial and antibiofilm activity of Carum copticum against antibiotic-resistant bacteria in planktonic and biofilm forms.
Mohammadi M; Masoumipour F; Hassanshahian M; Jafarinasab T
Microb Pathog; 2019 Apr; 129():99-105. PubMed ID: 30731188
[TBL] [Abstract][Full Text] [Related]
35. Bacteroides fragilis group: trends in resistance.
Fille M; Mango M; Lechner M; Schaumann R
Curr Microbiol; 2006 Feb; 52(2):153-7. PubMed ID: 16450067
[TBL] [Abstract][Full Text] [Related]
36. Antibacterial and antimutagenic activities of novel zerumbone analogues.
Santosh Kumar SC; Srinivas P; Negi PS; Bettadaiah BK
Food Chem; 2013 Nov; 141(2):1097-103. PubMed ID: 23790891
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity of Bacteroides fragilis to seven antimicrobial agents.
Oitmaa M; Benn R
Pathology; 1981 Oct; 13(4):697-703. PubMed ID: 7335376
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic susceptibility profiles of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan from 1990 to 1992.
Tanaka-Bandoh K; Kato N; Watanabe K; Ueno K
Clin Infect Dis; 1995 Jun; 20 Suppl 2():S352-5. PubMed ID: 7548596
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial resistance in the Bacteroides fragilis group in faecal samples from patients receiving broad-spectrum antibiotics.
Hansen KCM; Schwensen SAF; Henriksen DP; Justesen US; Sydenham TV
Anaerobe; 2017 Oct; 47():79-85. PubMed ID: 28445776
[TBL] [Abstract][Full Text] [Related]
40. Emergence of carbapenem resistance in Bacteroides fragilis in China.
Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
